Showing results (51-60 of 60) with videos related to
Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 60 results.
Breast Cancer Research and Treatment|September 25, 2020
Randomized phase II clinical trial and biomarker analysis of paclitaxel plus epirubicin versus vinorelbine plus epirubicin as neoadjuvant chemotherapy in locally advanced HER2-negative breast cancer with TEKT4 variationsYi-Zhou Jiang, Li-Ping Ge, Xi Jin, et al.Clinical Epigenetics|March 16, 2024
Identification of miR-20b-5p as an inhibitory regulator in cardiac differentiation via TET2 and DNA hydroxymethylationKe-Xin Li, Jia-Ru Li, Sheng-Jia Zuo, et al.Nature Communications|April 12, 2018
Characterization of PIK3CA and PIK3R1 somatic mutations in Chinese breast cancer patientsLi Chen, Liu Yang, Ling Yao, et al.Breast Cancer Research : BCR|March 16, 2016
Comprehensive transcriptome analysis identifies novel molecular subtypes and subtype-specific RNAs of triple-negative breast cancerYi-Rong Liu, Yi-Zhou Jiang, Xiao-En Xu, et al.Nature Medicine|June 25, 2025
Mobilizing antigen-presenting mast cells in anti-PD-1-refractory triple-negative breast cancer: a phase 2 trialSong-Yang Wu, Xi Jin, Yin Liu, et al.Cancer Research|April 28, 2018
PHF5A Epigenetically Inhibits Apoptosis to Promote Breast Cancer ProgressionYi-Zi Zheng, Meng-Zhu Xue, Hong-Jie Shen, et al.Cell Research|March 27, 2023
Subtyping-based platform guides precision medicine for heavily pretreated metastatic triple-negative breast cancer: The FUTURE phase II umbrella clinical trialYin Liu, Xiu-Zhi Zhu, Yi Xiao, et al.Science Advances|March 12, 2019
The endogenous retrovirus-derived long noncoding RNA TROJAN promotes triple-negative breast cancer progression via ZMYND8 degradationXi Jin, Xiao-En Xu, Yi-Zhou Jiang, et al.Cancer Letters|May 12, 2025
Efficacy and safety of inetetamab plus pertuzumab and nab-paclitaxel as neoadjuvant therapy for HER2+ breast cancer: A single-arm multicenter phase II clinical trialWen-Jia Zuo, Lin-Xiao-Xi Ma, Zhi-Hong Wang, et al.Cancer Cell|March 12, 2019
Genomic and Transcriptomic Landscape of Triple-Negative Breast Cancers: Subtypes and Treatment StrategiesYi-Zhou Jiang, Ding Ma, Chen Suo, et al.Pageof 6